182 related articles for article (PubMed ID: 7665599)
1. Configuration of the interferon-alpha/beta receptor complex determines the context of the biological response.
Ghislain J; Sussman G; Goelz S; Ling LE; Fish EN
J Biol Chem; 1995 Sep; 270(37):21785-92. PubMed ID: 7665599
[TBL] [Abstract][Full Text] [Related]
2. The proximal tyrosines of the cytoplasmic domain of the beta chain of the type I interferon receptor are essential for signal transducer and activator of transcription (Stat) 2 activation. Evidence that two Stat2 sites are required to reach a threshold of interferon alpha-induced Stat2 tyrosine phosphorylation that allows normal formation of interferon-stimulated gene factor 3.
Nadeau OW; Domanski P; Usacheva A; Uddin S; Platanias LC; Pitha P; Raz R; Levy D; Majchrzak B; Fish E; Colamonici OR
J Biol Chem; 1999 Feb; 274(7):4045-52. PubMed ID: 9933596
[TBL] [Abstract][Full Text] [Related]
3. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
4. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle-dependent modulation of alpha-interferon-inducible gene expression and activation of signaling components in Daudi cells.
Kumar R; Korutla L; Zhang K
J Biol Chem; 1994 Oct; 269(41):25437-41. PubMed ID: 7929242
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Jak-Stat pathway in cells that exhibit selective sensitivity to the antiviral effects of IFN-beta compared with IFN-alpha.
Grumbach IM; Fish EN; Uddin S; Majchrzak B; Colamonici OR; Figulla HR; Heim A; Platanias LC
J Interferon Cytokine Res; 1999 Jul; 19(7):797-801. PubMed ID: 10454351
[TBL] [Abstract][Full Text] [Related]
8. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
9. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
10. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.
Wong LH; Krauer KG; Hatzinisiriou I; Estcourt MJ; Hersey P; Tam ND; Edmondson S; Devenish RJ; Ralph SJ
J Biol Chem; 1997 Nov; 272(45):28779-85. PubMed ID: 9353349
[TBL] [Abstract][Full Text] [Related]
11. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
[TBL] [Abstract][Full Text] [Related]
12. Direct signal transduction via functional interferon-alphabeta receptors in CD34+ hematopoietic stem cells.
Giron-Michel J; Weill D; Bailly G; Legras S; Nardeux PC; Azzarone B; Tovey MG; Eid P
Leukemia; 2002 Jun; 16(6):1135-42. PubMed ID: 12040445
[TBL] [Abstract][Full Text] [Related]
13. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes.
Gimeno R; Lee CK; Schindler C; Levy DE
Mol Cell Biol; 2005 Jul; 25(13):5456-65. PubMed ID: 15964802
[TBL] [Abstract][Full Text] [Related]
14. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.
Subramaniam PS; Khan SA; Pontzer CH; Johnson HM
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883
[TBL] [Abstract][Full Text] [Related]
15. Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha.
Pansky A; Hildebrand P; Fasler-Kan E; Baselgia L; Ketterer S; Beglinger C; Heim MH
Int J Cancer; 2000 Mar; 85(5):720-5. PubMed ID: 10699955
[TBL] [Abstract][Full Text] [Related]
16. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
Abramovich C; Shulman LM; Ratovitski E; Harroch S; Tovey M; Eid P; Revel M
EMBO J; 1994 Dec; 13(24):5871-7. PubMed ID: 7813427
[TBL] [Abstract][Full Text] [Related]
17. Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase.
Rani MR; Leaman DW; Han Y; Leung S; Croze E; Fish EN; Wolfman A; Ransohoff RM
J Biol Chem; 1999 Nov; 274(45):32507-11. PubMed ID: 10542297
[TBL] [Abstract][Full Text] [Related]
18. IFN-alpha5 mediates stronger Tyk2-stat-dependent activation and higher expression of 2',5'-oligoadenylate synthetase than IFN-alpha2 in liver cells.
Larrea E; Aldabe R; Riezu-Boj JI; Guitart A; Civeira MP; Prieto J; Baixeras E
J Interferon Cytokine Res; 2004 Aug; 24(8):497-503. PubMed ID: 15320963
[TBL] [Abstract][Full Text] [Related]
19. Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity.
Lee CK; Bluyssen HA; Levy DE
J Biol Chem; 1997 Aug; 272(35):21872-7. PubMed ID: 9268319
[TBL] [Abstract][Full Text] [Related]
20. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
